DK35993A - Fremgangsmaade til rensning af vaevsprotein pp4 - Google Patents

Fremgangsmaade til rensning af vaevsprotein pp4

Info

Publication number
DK35993A
DK35993A DK035993A DK35993A DK35993A DK 35993 A DK35993 A DK 35993A DK 035993 A DK035993 A DK 035993A DK 35993 A DK35993 A DK 35993A DK 35993 A DK35993 A DK 35993A
Authority
DK
Denmark
Prior art keywords
purification
procedure
tissue protein
esp
opt
Prior art date
Application number
DK035993A
Other languages
English (en)
Other versions
DK35993D0 (da
Inventor
Hartmut Loebermann
Christiane Bornmann
Original Assignee
Berringwerke Aktiengesellschaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berringwerke Aktiengesellschaf filed Critical Berringwerke Aktiengesellschaf
Publication of DK35993D0 publication Critical patent/DK35993D0/da
Publication of DK35993A publication Critical patent/DK35993A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Conductive Materials (AREA)
  • Adhesives Or Adhesive Processes (AREA)
DK035993A 1986-12-18 1993-03-26 Fremgangsmaade til rensning af vaevsprotein pp4 DK35993A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863643182 DE3643182A1 (de) 1986-12-18 1986-12-18 Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4

Publications (2)

Publication Number Publication Date
DK35993D0 DK35993D0 (da) 1993-03-26
DK35993A true DK35993A (da) 1993-03-26

Family

ID=6316431

Family Applications (3)

Application Number Title Priority Date Filing Date
DK665787A DK167900B1 (da) 1986-12-18 1987-12-17 Middel til behandling og forebyggelse af haemostatiske forstyrrelser indeholdende vaevsprotein pp4
DK93360A DK36093D0 (da) 1986-12-18 1993-03-26 Fremgangsmaade til pasteurisering af vaevsprotein pp4
DK035993A DK35993A (da) 1986-12-18 1993-03-26 Fremgangsmaade til rensning af vaevsprotein pp4

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK665787A DK167900B1 (da) 1986-12-18 1987-12-17 Middel til behandling og forebyggelse af haemostatiske forstyrrelser indeholdende vaevsprotein pp4
DK93360A DK36093D0 (da) 1986-12-18 1993-03-26 Fremgangsmaade til pasteurisering af vaevsprotein pp4

Country Status (13)

Country Link
US (1) US5097019A (da)
EP (3) EP0457370B1 (da)
JP (1) JP2532535B2 (da)
KR (1) KR960007922B1 (da)
AT (2) ATE121940T1 (da)
AU (1) AU622102B2 (da)
CA (1) CA1338395C (da)
DE (3) DE3643182A1 (da)
DK (3) DK167900B1 (da)
ES (2) ES2042532T3 (da)
FI (1) FI91218C (da)
GR (1) GR3005247T3 (da)
PT (1) PT86393B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416151B (sv) * 1978-10-03 1980-12-01 Ake Gunnar Bolmgren Byggelement jemte mursten for tillverkning av elementet
DE3737239A1 (de) * 1987-11-03 1989-10-12 Behringwerke Ag Gentechnische herstellung von anticoagulatorischem protein pp4
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
DE4003773A1 (de) * 1990-02-08 1991-08-14 Behringwerke Ag Verfahren zur reinigung von lipocortinen
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
JP2747979B2 (ja) * 1994-08-19 1998-05-06 雪印乳業株式会社 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
DE19734648A1 (de) 1997-08-11 1999-02-18 Dade Behring Marburg Gmbh Verwendung von Annexinen als Lupus Antikoagulans Kontrolle oder Standard in Gerinnungstesten
ES2286247T3 (es) * 2001-02-21 2007-12-01 Alavita Pharmaceuticals, Inc. Proteinas anexinicas modificacdas y tratamiento de la trombosis.
US7645739B2 (en) * 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US20090291086A1 (en) * 2001-02-21 2009-11-26 Alavita Pharmaceuticals, Inc. Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
US7635680B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US6982154B2 (en) * 2002-02-21 2006-01-03 Surromed, Inc. Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease
GB2542391A (en) * 2015-09-17 2017-03-22 Annexin Pharmaceuticals Ab Process of manufacture

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461833A (en) * 1982-06-23 1984-07-24 University Patents, Inc. Chromatographically purifying proteolytic procoagulant enzyme from animal tissue extract
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
DE3315000A1 (de) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
DE3724726A1 (de) * 1987-07-25 1989-02-02 Behringwerke Ag Verfahren zur reinigung des plazentaren gewebeproteins pp4
US4896172A (en) * 1987-11-20 1990-01-23 Canon Kabushiki Kaisha Liquid injection recording apparatus including recording liquid circulation control

Also Published As

Publication number Publication date
PT86393B (pt) 1990-11-20
DK35993D0 (da) 1993-03-26
ES2042532T3 (es) 1993-12-16
DE3643182A1 (de) 1988-06-30
GR3005247T3 (da) 1993-05-24
DE3751281D1 (de) 1995-06-08
CA1338395C (en) 1996-06-11
DK36093A (da) 1993-03-26
EP0457370A1 (de) 1991-11-21
US5097019A (en) 1992-03-17
DK36093D0 (da) 1993-03-26
EP0457370B1 (de) 1995-05-03
EP0271885A3 (en) 1988-09-21
EP0457371A1 (de) 1991-11-21
FI91218B (fi) 1994-02-28
EP0271885A2 (de) 1988-06-22
AU8264687A (en) 1988-06-23
FI875518A (fi) 1988-06-19
ATE75618T1 (de) 1992-05-15
DK167900B1 (da) 1994-01-03
FI91218C (fi) 1994-06-10
AU622102B2 (en) 1992-04-02
ES2072490T3 (es) 1995-07-16
FI875518A0 (fi) 1987-12-16
KR880007088A (ko) 1988-08-26
KR960007922B1 (ko) 1996-06-17
DE3778852D1 (de) 1992-06-11
PT86393A (en) 1988-01-01
ATE121940T1 (de) 1995-05-15
DK665787A (da) 1988-06-19
JPS63165328A (ja) 1988-07-08
JP2532535B2 (ja) 1996-09-11
DK665787D0 (da) 1987-12-17
EP0271885B1 (de) 1992-05-06

Similar Documents

Publication Publication Date Title
DK35993A (da) Fremgangsmaade til rensning af vaevsprotein pp4
ATE86475T1 (de) Verwendung von milch-glycoproteinen zur mundhygiene.
BR9915573A (pt) Processo de preparação de uma composição protéica e uma fórmula infantil contendo a mesma
ATE114971T1 (de) Zwei-stufen-verfahren zur heilung schmerzenfreier wunden, sowie wässriges medium und topische salbe zur verwendung dazu.
NO832977L (no) Pasteurisert human-fibrinogen (hf), fremgangsmaate til dets fremstilling og dets anvendelse
DE68907679D1 (de) Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweg-geschwuerkrankheiten.
ATE112937T1 (de) Sterilfiltrierte kolostralmilch.
DE3379159D1 (en) Process for pasteurizing an antihaemophilic cryoprecipitate, and antihaemophilic cryoprecipitate so obtained
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
DE3786838D1 (de) Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern.
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
DK87190A (da) Fremgangsmaade til at regulere plantevaekst under anvendelse af svovlholdige organiske syrer
ATE336992T1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz- erkrankungen
DE3875016T2 (de) Therapeutikum zur behandlung von aids.
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
KR880001298A (ko) 화학적으로 변형되지 않은 γ- 글로부린을 열처리하는 방법
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
DE3680140D1 (de) Behandlung von parasiterkrankungen.
DK169190A (da) Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii
ES2008625A6 (es) Procedimiento para la obtencion de concentrados de aminoacidos; solubles y de alto grado de pureza, a partir de subproductos proteicos animales.
RU92003760A (ru) Устройство для индивидуального лечения
ES8704512A1 (es) Procedimiento para la obtencion de una solucion de aminoa- cidos y peptidos de origen animal